News BlueDot adds flu to its biothreat warning system BlueDot hit the headlines in the early stages of the pandemic for using its artificial intelligence platform to predict the outbreak and send out an alert before national
Oncology Treating primary bone cancer: The potential of listeria-base... In a new pharmaphorum podcast, Paul Romness, president and CEO of OS Therapies, discusses the company's work in osteosarcoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face